Skip to content

Leucosaccharide EPS study

Effects of Leucosaccharide on glucose regulation and gut environment in healthy volunteers; randomized, placebo-controlled, double blinded trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs031190088
Enrollment
40
Registered
2019-09-02
Start date
2019-09-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

[Placebo group] Subjects orally ingest placebo (5.0g of starch) with swallowing aid jelly within about 1 min once, and take food challenge test and microbiome test. [leucosaccharide 0.5g administratio

Sponsors

Irie Junichiro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy volunteers without any clinically diagnosed diseases, who meet all of the following criteria, are included in the study. 1) male and female aged 20 years or older and 65 years or younger 2) subjects who provide their written consent form to participate in the study after full explanation and enough understanding of the study 3) subjects who had a medical examination within 1 year, and who were not diagnosed with apparent glucose metabolism disorder (fasting plasma glucose of 126 mg/dl or higher, or casual plasma glucose of 200 mg/dl or higher) at that time

Exclusion criteria

Exclusion criteria: Subjects who meet any of the following criteria are excluded from the study. 1) subjects who are treated for clinically diagnosed diseases 2) subjects with malignant neoplasm 3) subjects with severe infection 4) subjects with uncontrolled psychiatric disorder 5) subjects with history of uncontrolled allergy to foods or drugs 6) subjects who are pregnant, possibly pregnant, within 90 days after delivery, or during breastfeeding 7) subjects who cannot provide written consent form, or who cannot understand the summary and the purpose of the study 8) subjects who are considered to be unsuitable for participation in the study by the responsible investigator or investigators due to the safety

Design outcomes

Primary

MeasureTime frame
Change of plasma glucose from baseline to 120 min after food intake

Secondary

MeasureTime frame
Dose-dependency of change of plasma glucose from baseline to 120 min after food intake Change of plasma glucose from baseline to 15, 30, 45, 60, and 90 min after food intake Ratio of area under the curve of plasma glucose during 0 to 120 min of food challenge test (leucosaccharide administration group / placebo group) Change of blood test biomarkers from baseline to 15, 30, 45, 60, 90, and 120 min after food intake Concentration of short-chain fatty acid in feces before and after food challenge test

Contacts

Public ContactYuya Nakajima

Keio University Hospital

yunakajima@keio.jp+81-3-5363-3797

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026